# Delivery Order #SPE2D326F297A

DLA Orders Morphine Sulfate from Hikma Pharmaceuticals

**Buyer:** Defense Logistics Agency

**Award Amount:** $131.94
**Ceiling:** $131.94

**Awarded:** July 24, 2026
**Period of Performance:** Jul 24, 2026 - Jul 27, 2026

**Identifier:** SPE2D326F297A
**NAICS:** 325411

This delivery order under the Defense Logistics Agency’s multi-year pharmaceutical supply vehicle procures morphine sulfate injection, 10 mg/mL, in vials. Hikma Pharmaceuticals USA Inc., a pharmaceutical manufacturer and supplier, will provide the medication for military medical needs. The order supports the availability of essential medicines for defense healthcare, although the supplied records do not specify quantities, delivery details, or broader operational requirements. The parent vehicle was competitively awarded; the records do not identify the competition method for this individual order. The order’s performance period is brief and falls within the ongoing parent agreement. No acquisition program, subcontractors, prior related orders, or original solicitation details are provided.

### Description

4572496868!MORPHINE SULFATE 10 MG/ML VIALML

[View original record](https://www.usaspending.gov/award/CONT_AWD_SPE2D326F297A_9700_SPE2D020D0006_9700)
